Virotherapy Manufacturing

Source: ReciBioPharm

Seamlessly delivering your virotherapy

With industry-leading viral expertise, ReciBioPharm navigates the rapidly evolving field of virotherapy to support the development and manufacturing of your gene therapies, viral vector vaccines and oncolytic viruses (OVs).

Your dedicated virotherapy partner

As an experienced global CDMO, we are dedicated to meeting your evolving virotherapy development and manufacturing needs through a collaborative approach, helping to progress your OVs, viral vector vaccines and gene therapies.

Leveraging a network of clinical and commercial-ready sites across the EU and the US, we prioritise operational excellence, an innovative mindset and customer connectivity to reliably deliver your virotherapy.

Explore our virotherapy services

  • Plasmid DNA manufacturing
  • Cell and virus starting materials
  • Oncolytic viruses
  • Gene therapy viral vectors
  • Viral vector vaccines
  • ATMP fill and finish (automated and manual services)
  • Analytical and process development services

Progressing your virotherapy seamlessly

Our comprehensive virotherapy development and manufacturing services offer a seamless journey for your OV, viral vector vaccine or gene therapy project as it progresses to patients.

Relying on our integrated offering encompassing plasmid production, virotherapy analytical and process development and cGMP manufacturing, as well as ATMP fill and finish, we can help accelerate your project from clinical phases to commercialisation.

By streamlining the navigation of the CMC pathway, we can deliver your transformative medicine to patients sooner.